Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5685244 | 0.88 | CHRNB2 (0.37) | HTR2AHTR2CHTR2B | |
| SCHEMBL5688182 | 0.83 | HTR2A (0.32) | HTR2AHTR2CHTR2B | |
| SCHEMBL1451016 | 0.78 | PGR (0.33) | DRD2 | |
| SCHEMBL3202689 | 0.73 | MAOA (0.46) | DRD2 | |
| SCHEMBL17541407 | 0.72 | MTNR1B (0.39) | — | |
| SCHEMBL4812053 | 0.72 | CHRNB2 (0.30) | HTR2AHTR2CHTR2B | |
| SCHEMBL5688247 | 0.72 | PLAU (0.31) | — | |
| SCHEMBL5685247 | 0.72 | PLAU (0.31) | — | |
| SCHEMBL1451835 | 0.72 | CHRNB2 (0.55) | — | |
| SCHEMBL15147096 | 0.71 | HTR2A (0.57) | PDPK1HTR2AHTR2CHTR2BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10144791-B2 | Molecular weight control of polyolefins using halogenated bis-phenylphenoxy catalysts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-12-04 | — | — | US | claimed |
| US-20170158790-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC | 2017-06-08 | — | — | US | claimed |
| US-8063242-B2 | for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion | DOMPE PHA.R.MA S.P.A. (IT) | 2011-11-22 | — | — | US | claimed |
| US-20050038119-A1 | 2-Aryl-propionic acids and pharmaceutical compositions containing them | DOMPÉ FARMACEUTICI S.P.A. (IT) | 2005-02-17 | — | — | US | claimed |
| EP-1455773-A1 | 2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dompé S.P.A. (IT) | 2004-09-15 | — | — | EP | claimed |
| WO-2003043625-A1 | 2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPE S.P.A. (IT) | 2003-05-30 | — | — | WO | claimed |
| EP-3925989-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | Dow Global Technologies LLC (US) | 2021-12-22 | — | — | EP | disclosed |
| CN-113201084-A | Molecular weight control of polyolefins using halogenated bisphenylphenoxy catalysts | 陶氏环球技术有限责任公司 | 2021-08-03 | — | — | CN | disclosed |
| US-10836697-B2 | Process for the preparation of lightly-branched hydrophobes and the corresponding surfactants and applications thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-11-17 | — | — | US | disclosed |
| EP-2797963-B1 | HYPERBRANCHED OLEFIN OIL-BASED DIELECTRIC FLUID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-03 | — | — | EP | disclosed |
| US-20190112250-A1 | PROCESS FOR THE PREPARATION OF LIGHTLY-BRANCHED HYDROPHOBES AND THE CORRESPONDING SURFACTANTS AND APPLICATIONS THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-04-18 | — | — | US | disclosed |
| US-10196336-B2 | Process for the preparation of lightly-branched hydrophobes and the corresponding surfactants and applications thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-02-05 | — | — | US | disclosed |
| US-10144791-B2 | Molecular weight control of polyolefins using halogenated bis-phenylphenoxy catalysts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-12-04 | — | — | US | disclosed |
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC | 2011-11-17 | — | — | US | disclosed |
| EP-2229942-A1 | 2-Aryl-propionic acids and pharmaceutical compositions containing them | Dompe S.p.A. (IT) | 2010-09-22 | — | — | EP | disclosed |
| US-20060122064-A1 | Amides and method for plant diseases control with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1640360-A1 | AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20050038119-A1 | 2-Aryl-propionic acids and pharmaceutical compositions containing them | DOMPÉ FARMACEUTICI S.P.A. (IT) | 2005-02-17 | — | — | US | disclosed |
| EP-1455773-A1 | 2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dompé S.P.A. (IT) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003043625-A1 | 2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPE S.P.A. (IT) | 2003-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10836697-B2 | Process for the preparation of lightly-branched hydrophobes and the corresponding surfactants and applications thereof | ERG28, CLTB, CHN2 | PDPK1 4586/4885HTR2A 3957/4885HTR2C 3367/4885 |
| US-20060122064-A1 | Amides and method for plant diseases control with the same | ARG1, ARGLU1, ARG2 | PDPK1 4243/4885HTR2A 3356/4885HTR2C 3581/4885 |
| US-10196336-B2 | Process for the preparation of lightly-branched hydrophobes and the corresponding surfactants and applications thereof | ERG28, CLTB, CHN2 | PDPK1 4586/4885HTR2A 3957/4885HTR2C 3367/4885 |
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | WEE2, NOTUM, WEE1 | PDPK1 1470/4885HTR2A 4613/4885HTR2C 4012/4885 |
| US-20190112250-A1 | PROCESS FOR THE PREPARATION OF LIGHTLY-BRANCHED HYDROPHOBES AND THE CORRESPONDING SURFACTANTS AND APPLICATIONS THEREOF | ERG28, CLTB, CHN2 | PDPK1 4604/4885HTR2A 3955/4885HTR2C 3410/4885 |
| US-20050038119-A1 | 2-Aryl-propionic acids and pharmaceutical compositions containing them | CXCR2, FPR1, CCR2 | PDPK1 1100/4885HTR2A 1663/4885HTR2C 1920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.